I-Mab (IMAB) Competitors

Septerna (NASDAQ:SEPN) and I-Mab (NASDAQ:IMAB) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings, community ranking and dividends.

Which has better earnings & valuation, SEPN or IMAB?

Septerna has higher earnings, but lower revenue than I-Mab.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Septerna	$981K	252.11	N/A	N/A	N/A
I-Mab	$3.27M	20.30	-$206.44M	N/A	N/A

Does the MarketBeat Community favor SEPN or IMAB?

I-Mab received 55 more outperform votes than Septerna when rated by MarketBeat users. However, 71.43% of users gave Septerna an outperform vote while only 64.52% of users gave I-Mab an outperform vote.

Company	Underperform	Outperform
Septerna	Outperform Votes 5 71.43%	Underperform Votes 2 28.57%
I-Mab	Outperform Votes 60 64.52%	Underperform Votes 33 35.48%

Do analysts prefer SEPN or IMAB?

Septerna currently has a consensus price target of $33.00, suggesting a potential upside of 492.46%. I-Mab has a consensus price target of $7.00, suggesting a potential upside of 758.68%. Given I-Mab's stronger consensus rating and higher probable upside, analysts plainly believe I-Mab is more favorable than Septerna.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Septerna	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
I-Mab	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33

Do institutionals & insiders have more ownership in SEPN or IMAB?

38.4% of I-Mab shares are held by institutional investors. 22.1% of I-Mab shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Is SEPN or IMAB more profitable?

Company	Net Margins	Return on Equity	Return on Assets
Septerna	N/A	N/A	N/A
I-Mab	N/A	N/A	N/A

Does the media refer more to SEPN or IMAB?

In the previous week, Septerna had 12 more articles in the media than I-Mab. MarketBeat recorded 14 mentions for Septerna and 2 mentions for I-Mab. Septerna's average media sentiment score of 0.38 beat I-Mab's score of 0.00 indicating that Septerna is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Septerna	1 Very Positive mention(s)	5 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
I-Mab	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

I-Mab beats Septerna on 7 of the 12 factors compared between the two stocks.